FDA Approved: MYOVIEW — Supplemental Application (Medi-Physics Inc. dba GE Healthcare)

View source ↗

Summary

FDA approved a supplemental application for Myoview (technetium-99m tetrofosmin) to update its labeling after review.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• MYOVIEW (TETROFOSMIN)

Snippet

SUPPL AP for MYOVIEW (TETROFOSMIN)